Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Cardiovascular Conditions and Diseases
      • Digital Health
      • Health Policy
      • Immunity and Infectious Diseases
      • Joint Health and Mobility
      • Respiratory and Lung Health
      • Spinal Cord Injury and Rehabilitation
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • Ovarian Cancer Research Centre
      • Vancouver Prostate Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • CST Cerner at VCH
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Education and Training
      • Communications and Branding
      • Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Innovation and Partnership
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. Nader Al Nakouzi

Nader Al Nakouzi

Adjunct Professor
Academic Appointment
Adjunct Professor
Degrees / Designations

DPhil, MBA

Contact Info
nalnakouzi@prostatecentre.com
604-875-4111 ext.61746
nader_alnakouzi
nader-al-nakouzi-444a5815/

Biography

Dr. Nader Al Nakouzi is a research scientist at the Vancouver Prostate Centre. He obtained a Doctor of Philosophy in cancer biology from the University of Paris-XI in 2011 and a specialized Master of Business Administration in pharmaceutical and health care management from ISC-Paris. From 2012 to 2016, he pursued his postdoctoral training with Drs. Martin Gleave and Mads Daugaard. 

Dr. Al Nakouzi has a background in molecular and cell biology, with 10 years of experience in the development of cancer therapeutics and molecular mechanisms of drug resistance. Dr. Al Nakouzi’s primary research goal is to identify and characterize novel drug targets to treat late-stage prostate cancer. His ongoing research focuses on molecular and biochemical events underlying the prostate cancer progression, glycocalyx formation, chemotherapy resistance mechanisms and posttranslational modifications in cancer.

Dr. Al Nakouzi has published original research in top-tier scientific journals and received numerous national and international awards, including an ARC-Doctoral award-France, American Association for Cancer Research Scholar-in-Training award, Terry Fox Foundation Scholar-in-Training award, MITACS Elevate fellowship, CUA-Astellas grant, SPORE-NIH grant and Canadian Institutes of Health Research funding.

News and Awards

Novel discovery slowed prostate cancer growth by targeting its sugar coat

Oct 31, 2022

Publications

  • Nature communications -

    Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancer.

    Al-Nakouzi N, Wang CK, Oo HZ, Nelepcu I, Lallous N, Spliid CB, Khazamipour N, Lo J, Truong S, Collins C, Hui D, Esfandnia S, Adomat H, Clausen TM, Gustavsson T, Choudhary S, Dagil R, Corey E, Wang Y, Chauchereau A, Fazli L, Esko JD, Salanti A, Nelson PS, Gleave ME, Daugaard M
  • Cancer cell -

    Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein.

    Salanti A, Clausen TM, Agerbæk MØ, Al Nakouzi N, Dahlbäck M, Oo HZ, Lee S, Gustavsson T, Rich JR, Hedberg BJ, Mao Y, Barington L, Pereira MA, LoBello J, Endo M, Fazli L, Soden J, Wang CK, Sander AF, Dagil R, Thrane S, Holst PJ, Meng L, Favero F, Weiss GJ, Nielsen MA, Freeth J, Nielsen TO, Zaia J, Tran NL, Trent J, Babcook JS, Theander TG, Sorensen PH, Daugaard M
  • EMBO molecular medicine -

    Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis.

    Al Nakouzi N, Wang CK, Beraldi E, Jager W, Ettinger S, Fazli L, Nappi L, Bishop J, Zhang F, Chauchereau A, Loriot Y, Gleave M
  • European urology -

    Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies.

    Al Nakouzi N, Le Moulec S, Albigès L, Wang C, Beuzeboc P, Gross-Goupil M, de La Motte Rouge T, Guillot A, Gajda D, Massard C, Gleave M, Fizazi K, Loriot Y
  • The Journal of clinical investigation -

    Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor models.

    Nappi L, Aguda AH, Nakouzi NA, Lelj-Garolla B, Beraldi E, Lallous N, Thi M, Moore S, Fazli L, Battsogt D, Stief S, Ban F, Nguyen NT, Saxena N, Dueva E, Zhang F, Yamazaki T, Zoubeidi A, Cherkasov A, Brayer GD, Gleave M
Working in the lab

Are you a researcher?

Update or create your researcher profile on our online directory.

Update Profile    Create New Profile

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • Twitter
  • LinkedIn

© 2023 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy